Abstract
With the purpose of designing new chemical entities with enhanced inhibitory potencies against Mycobacterium tuberculosis, the 3D-QSAR CoMFA study carried out on biphenyl analogs of the tuberculosis drug, (6S)-2-nitro-6-{[4-trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824), is presented here. The developed model showed a good correlative and predictive ability. The final QSAR models as well as the information gathered from 3D contour maps should be useful for the design of novel PA-824 analogs having improved anti-TB activity.
Similar content being viewed by others
References
Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959–5967. doi:10.1021/ja00226a005
Denny WA, Palmer BD, Thompson AM, Sutherland HS, Blaser A, Kmentova I, Franzblau SG, Wan B, Wang Y, Ma Z (2010) Synthesis and structure-activity studies of biphenyl analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy) benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). J Med Chem 53:282–294. doi:10.1021/jm901207n
Hadda TB, Bennani B, Kerbal A, Daoudi M, Filali Baba B, Al Houari G, Jalbout AF, Mimouni M, Benazza M, Demailly G, Akkurt M, Öztürk Yýldýrým S (2007) Combined drug design of potential Mycobacterium tuberculosis and HIV-1 inhibitors: 3′,4′-di-substituted -4′H-spiro[isothiochromene-3,5′-isoxazol]-4(1H)-one. ARKIVOC XVI:19–40
Masand VH, Patil KN, Nazerruddin GM, Jawarkar RD, Bajaj SO (2010) Correlation potential of Wiener index vis-a-vis molecular refractivity: anti-malarial activity of xanthone derivatives. Org Chem Indian J 6(1):30–38
Singh SK, Dessalew N, Bharatam PV (2007) 3D-QSAR CoMFA study on oxindole derivatives as cyclin dependent kinase 1 (CDK1) and cyclin dependent kinase 2 (CDK2) inhibitors. Med Chem 3:75–84
Zhang N, Zhong R (2010) Docking and 3D-QSAR studies of 7-hydroxycoumarin derivatives as CK2 inhibitors. Eur J Med Chem 45:292–297. doi:10.1016/j.ejmech.2009.10.011
Acknowledgment
Authors are thankful to Dr. F.C. Raghuwanshi, Principal, Vidya Bharati Mahavidyalaya, Amravati for providing necessary help and support
Conflict of interest
Authors disclose no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Masand, V.H., Jawarkar, R.D., Mahajan, D.T. et al. QSAR and CoMFA studies of biphenyl analogs of the anti-tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo [2,1-b][1,3]oxazine (PA-824). Med Chem Res 21, 2624–2629 (2012). https://doi.org/10.1007/s00044-011-9787-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-011-9787-x